<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Clinical research Prescription Drug User Fee Act Center for Biologics Evaluation and Research FDA Special Protocol Assessment Center for Drug Evaluation and Research Dermatologic and Ophthalmic Drugs Advisory Committee Oncology Drug Advisory Committee Food and Drug Administration Medicine Health |
Add to Reading List |
Guidance for Industry: Independent Consultants for Biotechnology Clinical Protocols | Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA StaffDocID: 1ogsZ - View Document |
 | Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docxDocID: 1gkCa - View Document |
 | Global Healthy Living Foundation 515 North Midland Avenue Upper Nyack, New York 10960 USA +1 845 348 0400DocID: 1g1KY - View Document |
 | Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified IndicationsDocID: 1fuJJ - View Document |
 | DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for IndustryDocID: 1aZ0Q - View Document |